Podcasts about prescribing

Welcome back to the Homeopathy247 podcast! In Episode 204, Mary Greensmith sits down with the brilliant homeopath Madhavi Naik to demystify one of the most common—and often misunderstood—terms in holistic health: constitutional prescribing. If you have ever wondered why homeopaths ask such detailed questions about your personality, sleep habits, and food cravings, this episode will clear it all up! What is Constitutional Prescribing? When you visit a conventional doctor, the focus is usually on your specific physical complaint (like a headache or a cough). Homeopathy works beautifully in reverse! Madhavi explains that a constitutional prescription looks at the totality of your symptoms, prioritizing them in a specific hierarchy: Mental Generals: Your emotional state, intellect, and memory. This is the most important layer! Physical Generals: How your body interacts with the environment. Do you run hot or cold? What are your sleep patterns, energy levels, and food cravings? Physical Particulars: Your chief complaint (the main reason you sought help). By looking at the complete picture, a homeopath finds a remedy that matches your current, unique state of being. Layers of Healing and Evolving States Madhavi highlights that nobody is locked into a single "remedy personality" for life. We are constantly evolving, and so are our remedy needs! She shares a great case of a 50-year-old caregiver who needed Arnica for physical soreness, Bryonia for an acute allergy cough, and finally Sepia to address the deeper, constitutional layer of caregiver overwhelm and insomnia. Obstacles to Cure A homeopathic remedy cannot override a physical obstacle. Madhavi shares a funny personal story from her days as a medical student: she took Staphysagria for severe eye pain, only to realize two days later that she simply had a stray eyelash trapped against her cornea! Homeopathy works with your body, but maintaining causes—like poor nutrition, environmental toxins, or physical irritants—must be addressed for true healing to take place. Important links mentioned in this episode: Visit Madhavi's website: https://naturalbridgeshomeopathy.com/ Know more about Madhavi: https://homeopathy247.com/professional-homeopaths-team/madhavi-naik/   You can also subscribe to our podcast channels available on your favourite podcast listening app below: Apple Podcast: https://podcasts.apple.com/us/podcast/homeopathy247-podcast/id1628767810 Spotify: https://open.spotify.com/show/39rjXAReQ33hGceW1E50dk Follow us on our social media accounts: Facebook: https://www.facebook.com/homeopathy247 Instagram: https://www.instagram.com/homeopathy247 You can also visit our website at https://homeopathy247.com/

Thought hormones were just for period regulation and menopause support? In this eye-opening conversation, GP and hormone specialist Dr Louise Newson joins Liz to explain the surprising role progesterone, oestrogen and testosterone play in everything from brain health to inflammation.They discuss the misinformation that's letting women down, the crucial difference between body-identical and synthetic hormones, and why progesterone may be far more powerful than most of us realise.Louise also explains why cholesterol is essential for hormone production, how testosterone is a natural painkiller, and the questions every midlife woman should feel confident asking about her health and treatment options.In this episode:· The difference between synthetic and bioidentical hormones· The truth about cholesterol· Why progesterone might play a role in mental health care· Why the contraceptive pill needs updating· Prescribing testosterone as a natural painkiller· Why post-hysterectomy women still need progesterone More from Louise:· Follow Louise on Instagram· Order Louise's book, The Power of Hormones· Get tickets for Louise's tour Breaking The Cycle: The Power of Hormones Get in touch with a question for Liz:· Email: podcast@lizearlewellbeing.com· WhatsApp: 07518 471 846 More from Liz:· Order Liz's new book – How to Age· A Better Second Half· Follow Liz on Instagram· Follow Liz Earle Wellbeing on Instagram Host: Liz EarleProducer: Anouszka Tate (Fresh Air Production) Social Media Manager: Naomi van GeelenContent Writer: Lucy ParleyHead of Brand: Ellie SmithSome links may be affiliate links, which help support the show at no extra cost to you. Read our Affiliate Policy for more information. Hosted on Acast. See acast.com/privacy for more information.

I had the privilege of learning from fellow Greenwall Faculty Scholar Lisa Harris about a term she termed, "dangertalk."  As an ob/gyn and abortion provider, Lisa found the debate around the legality of abortion so polarizing that it created a false dichotomy: you're either for or against.  Any talk about misgivings, uncertainty, ambiguity, or ambivalence was silenced.  Talking about these issues in the face of polarization was deemed dangerous and undermining to one side or another. "How could you?" For Lisa's work in finding common ground and embracing nuance she was awarded the 2023 Bernard Lo Award for forging connections across divisions. In today's podcast we focus on the equivalent experience of moral uncertainty, distress, and residue among prescribers of medical aid in dying.  We are joined by Carly Zapata and Dani Chammas, prescribers of medical aid in dying in California. We discuss: Their journey prescribing medical aid in dying, and reasons for choosing to prescribe The legality of prescribing in California.  We compare California to Canada, as we have previously on this podcast. We discuss new limited survey data suggesting that legal barriers may not explain the remarkable 20 fold differences in use of medical aid in dying between California and Canada; rather, Canada has 6x the number of providers per capita as California, and much greater awareness of the legality of medical aid in dying. We talk about cases that are not as clear - e.g. people who have voluntarily stopped eating and drinking.   Moral issues, including ambiguity and ambivalence, distress and residue. For example the moral distress created when a patient requests medical aid in dying due to what is clearly a systems failure (see this Atlantic article for clear examples from Canada).  We ask if they sometimes feel frustrated that more people who are in favor of medical aid in dying are not prescribing, instead leaving prescribing responsibility to a relatively small group of clinicians.   How core ethical ideas might lead to very different conclusions about medical aid in dying, and ways Dani teaches ethics to trainees.   Psychological models that can help navigate this complex terrain with patients and families, including formulations and countertransference.   And I can't believe I haven't played, "I will follow you into the dark" previously - but google couldn't find it - really?  In 400+ GeriPal podcasts?  Great song.  So fitting.  My son Renn plays guitar on the audio only version. -Alex Smith   Additionally, some take home points, sent by Dani after recording: (1) Holding the dialectic: On one hand, people deserve the highest level of attention to their personhood and their suffering—an effort that, at times, can soften or even resolve a desire for hastened death. And on the other hand, some people will authentically experience this as the most values-aligned way of dying, given their circumstances. (2) Learning to accept that while laws create the safety rails, within those boundaries, morality is pluralistic. Both patients and clinicians bring deeply held moral frameworks to these decisions—and those frameworks deserve to be acknowledged and respected. (3) We have to be willing to ask the hard questions—and to show up for one another as we do. Because this work, more than almost any other, has taught us the profound impact of not feeling alone when navigating grey terrain. I view the discussion as an invitation for our field to not necessarily to become more certain, but to be willing to wrestle with the hard questions—while still showing up with rigor and compassion. And to remember that our patients are people before they are cases. If we can stay close enough to truly know them, we're much more likely to respond in ways that honor both their suffering and their dignity—whatever path that ultimately leads to.

To learn more about valuable resources for entrepreneurs and business owners, please visit https://www.sbprou.com/Prescribing without a Diagnosis is Malpractice is covered in this podcast, along with the following subjects:***************************************Join Andrew Frazier for an insightful conversation with John W. Kennedy on “Prescribing Without a Diagnosis is Malpractice.” Dr. Kennedy, a seasoned engineer, entrepreneur, and former CEO of New Jersey Manufacturing Extension Program, will share why accurate diagnosis is critical before implementing business solutions. Together, they'll explore how leaders and entrepreneurs can avoid costly mistakes by identifying root causes, applying strategic thinking, and building systems that drive sustainable growth and long-term success.John W. Kennedy, Ph.D. is the former CEO of the New Jersey Manufacturing Extension Program (NJMEP), where he led the organization for over a decade, helping drive growth, innovation, and competitiveness across New Jersey's manufacturing sector. During his tenure, NJMEP supported thousands of manufacturers and contributed billions in economic impact while expanding its reach and national leadership within the NIST Manufacturing Extension Partnership network.An engineer, entrepreneur, and former business owner, Dr. Kennedy brings more than 20 years of experience in manufacturing and engineering. He has held leadership roles across multiple companies and remains active in economic development, continuing to support industry growth through advisory and consulting work. LinkedIn:   / john-w-kennedy-ph-d-08331013  Website: https://www.njmep.org/

Website

We spend a lot of time on this podcast exploring what's happening on the inside - our thoughts, our nervous system, our stress and worry. But what about the world around us? Today, Dr Jodi Richardson is joined by registered landscape architect and founder of Otara, Debbie Laporte, to explore how the spaces we inhabit - especially outdoor spaces - have a profound impact on our mental health and wellbeing.With over twenty years of experience designing school grounds, nature play areas and community environments across Australia and Europe, Debbie brings a fascinating perspective on why so many of us are struggling...and why the answer might be closer than we think.In this conversation, Jodi and Debbie discuss:Why humans are spending more time indoors than ever before, and what that's costing us mentally and emotionallyThe concept of nature deficit disorder and the growing movement of doctors prescribing time in natureWhat nature play actually is (and why it's not just for kids!)The powerful role of choice and risk in play, and what that means for raising resilient childrenSimple, low-cost ways to improve your outdoor spaces so you actually want to use themWhy even five minutes outside can completely reset your mood and productivityWhether you have a big backyard or just a front doorstep, this episode will leave you looking at the spaces around you in a whole new way - and feeling inspired to get outside.Find Debbie and her work at www.orterra.com.au or on Instagram, Facebook and LinkedIn.See omnystudio.com/listener for privacy information.

Access to medications for opioid use disorder (MOUD) remains a critical component of addressing the ongoing opioid crisis, and recent federal authorization now allows pharmacists to independently prescribe buprenorphine following appropriate training. This course reviews the regulatory changes, outlines clinical and operational considerations for pharmacist-led MOUD prescribing, and discusses the opportunities and responsibilities that accompany expanded prescriptive authority. You will gain practical insight into how integrating MOUD prescribing into pharmacy practice can improve treatment access while maintaining safe, evidence-based care. HOSTRachel Maynard, PharmDGameChangers Podcast Host and Clinical Editor, CEimpactLead Editor, PyrlsGUESTKorey Kreider, PharmDPharmacist OwnerMedicine ManPharmacists, REDEEM YOUR CPE HERE!CPE is available to Health Mart franchise members onlyTo learn more about Health Mart, click here: https://join.healthmart.com/PRACTICE RESOURCEReceive the exclusive Practice Resource to use as a reference guide for this episode by enrolling in the course. Click here to enroll!CPE INFORMATIONLearning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:1. Describe recent federal policy changes authorizing pharmacists to independently prescribe buprenorphine for opioid use disorder.2. Identify clinical, regulatory, and workflow considerations associated with integrating MOUD prescribing into pharmacy practiceRachel Maynard and Korey Kreider have no relevant financial relationships with ineligible companies to disclose. 0.1 CEU/1.0 HrUAN: 0107-0000-26-150-H01-PInitial release date: 5/11/2026Expiration date: 5/11/2027Additional CPE details can be found here.

Access to medications for opioid use disorder (MOUD) remains a critical component of addressing the ongoing opioid crisis, and recent federal authorization now allows pharmacists to independently prescribe buprenorphine following appropriate training. This course reviews the regulatory changes, outlines clinical and operational considerations for pharmacist-led MOUD prescribing, and discusses the opportunities and responsibilities that accompany expanded prescriptive authority. You will gain practical insight into how integrating MOUD prescribing into pharmacy practice can improve treatment access while maintaining safe, evidence-based care.HOSTRachel Maynard, PharmDGameChangers Podcast Host and Clinical Editor, CEimpactLead Editor, PyrlsGUESTKorey Kreider, PharmDPharmacist OwnerMedicine ManGET CE FOR LISTENING!Stay Compliant. Grow Clinically. Practice with Confidence. Pharmacist CE Subscription: All your CE in one convenient subscription.All episodes, CE, and Practice Resources for the GameChangers Clinical Update is included with your Pharmacist CE Subscription. But wait…there's even more!The Pharmacist CE Subscription includes: -  Compliance and licensure CE -  GameChangers Clinical Updates-  Practical continuing education across patient care topics *The subscription does not include microcredentials or certificates, which are available separately for pharmacists seeking specialized service training. Purchase Now!PRACTICE RESOURCEReceive the exclusive Practice Resource to use as a reference guide for this episode by purchasing the GameChangers Clinical Update Series. CPE REDEMPTIONThis course is accredited for continuing pharmacy education! Click the link below that applies to you to take the exam and evaluation to claim credit:If you are already enrolled in this course, click here to redeem your credit. To purchase the Clinical Update Series and claim your CPE credit, click here or to purchase this course individually, click here. CPE INFORMATIONLearning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:1. Describe recent federal policy changes authorizing pharmacists to independently prescribe buprenorphine for opioid use disorder.2. Identify clinical, regulatory, and workflow considerations associated with integrating MOUD prescribing into pharmacy practice.Rachel Maynard and Korey Kreider have no relevant financial relationships with ineligible companies to disclose. 0.1 CEU/1.0 HrUAN: 0107-0000-26-150-H01-P Initial release date: 5/11/2026Expiration date: 5/11/2027Additional CPE details can be found here.Follow CEimpact on Social Media:LinkedInInstagram

RFK Jr.'s push to reduce antidepressant dependence is drawing fire from MSNBC and Reuters, and Jordan and Nate break down why. With 1 in 6 American adults on SSRIs and the global market generating $20 billion per year, the push for deprescribing pathways backed by a new CMS billing code is a genuine disruption to pharma revenue. RFK shares a personal account of a family member's SSRI withdrawal he describes as harder than heroin detox. The show then dismantles the hantavirus media cycle: 5 cases on a cruise ship, Moderna already codeveloping a vaccine, and Robert Malone reminding everyone that a lightning strike is statistically more likely. FDA Commissioner Makary's admission that the FDA deliberately misled the public on dietary fat for nearly two decades gets its moment, followed by a DOJ investigation into the Big Four meatpackers for antitrust violations and foreign ownership concerns. The episode closes with a discussion on statin overuse, CoQ10 depletion, thyroid health, iodine sources, and the structural problem of corporate consolidation across farming and food supply chains.

Is healthcare becoming too much like a repair shop?In this episode, we are joined by Professor Sir Gregor Smith, Chief Medical Officer for Scotland, for a wide-ranging conversation on 10 years of Realistic Medicine and the themes explored in his latest report, Critical Connections.Together we explore the need to create a better balance between biography and biology when practicing evidence based medicine. We discuss why meaningful human connection matters so profoundly to health, and how modern healthcare risks drifting into “transactional industrial care.”The discussion ranges from prevention and sustainability to polypharmacy, de-prescribing and the challenge of measuring what truly matters through PROMs (Patient-Reported Outcome Measures) and PREMs (Patient-Reported Experience Measures).Gregor reflects on the formative experiences that shaped his thinking as a GP, the development of Scotland's polypharmacy guidance, and why Realistic Medicine was always intended as a grassroots movement rather than a top-down programme.This is a conversation about careful and kind care — and what it would take to build health systems that genuinely help people live well.We discuss in detail Gregor's own report ‘Realistic Medicine - Critical Connections'. It is one of the most insightful and important papers we have ever read and is a must-read for our listeners!https://www.gov.scot/publications/chief-medical-officers-annual-report-2024-2025-realistic-medicine-critical-connections/As with all of our guests, Gregor shares with us his Memory Evoking Medicine, a career anthem and book. Another appearance by a popular author, a song choice with a story and a drug that takes us right back to the very formation of the podcast!Gimmo commits podultary! Listen to his appearance on the excellent ‘Knowing You' podcast with friend of the show Sarah Cripps on all major podcast platforms: https://www.linkedin.com/posts/sarahcripps_leadership-qualityimprovement-mentalhealth-share-7442815050563809280-nDgR Link to “ Thinking Critically About AI Lectures”  by Jessica Morley https://youtu.be/03bJ8BcYs1c?si=j9eHuCWVJEng7cO1From Prescription to Ocean — A TEDx Talk by Jamie HayesWe're incredibly proud to share that Aural Apothecary co-host Jamie Hayes has taken to the TEDx stage with a thought-provoking talk:  Prescription to Ocean: The Hidden Impact of Medicineshttps://www.youtube.com/watch?v=swCLNaAG5qYJamie explores a fascinating and urgent question: What happens to our medicines once they leave the prescription pad — and how do they impact the world beyond the patient? It's a journey that connects healthcare, the environment, and our shared responsibility for the future. You'll never think about prescribing (or taking) medicines in quite the same way again.Please take a few minutes to watch, reflect, and share — this is a conversation worth having.Please follow us on LinkedIn! Let us know what you think of the show. https://www.linkedin.com/company/auralapothecary/You can listen to the Aural Apothecary playlist here; https://open.spotify.com/playlist/3OsWj4w8sxsvuwR9zMXgn5?si=tiHXrQI7QsGtSQwPyz1KBg You can view the Aural Apothecary Library here;  https://litalist.com/shelf/view-bookcase?publicId=KN6E3OOur website is https://www.theauralapothecary.com/To get in touch follow us on LinkedIn, Bluesky and X @auralapothecary or email us at auralapothecarypod@gmail.com.Don't forget to rate us and comment wherever you have got this podcast from.

Prescribing time in nature is something that has come of age. It isn't just a West Coast thing that requires a tie-dyed t-shirt. Dr. Melissa Lem kindly tells us some 20,000 Canadian health professionals agree that to reduce stress, and maybe even extend your quality of life, you need to see, hear, feel, the natural world.After having Meg Carney and Bill Steer on this program it was a natural next step to have this conversation with Melissa. Dr. Melissa Lem is a Vancouver family physician who is taking the benefits of being in nature across the country and around the world. The PaRx initiative encourages us to take as little as two hours a week to be healthier people in healthier communities.

Send us Fan MailDoctors in North America are now prescribing something you can't buy at a pharmacy… and it's backed by a growing body of science. Jennie McCaffrey is the Vice President of Health & Education at the BC Parks Foundation ( https://bcparksfoundation.ca/ ), where she leads initiatives designed to connect people to nearby nature for the benefit of both human health and the planet.With a career spanning environmental education, behavior change, and large-scale community engagement, Jennie has worked across nonprofits, government, and industry to inspire action on biodiversity, climate, and public health. Her work has helped build movements around ambitious conservation goals like 25x25 and 30x30, while also translating those global targets into everyday human behaviors - getting people outside, active, and reconnected with nature.Before stepping into her current role, Jennie led education and engagement efforts at the Invasive Species Council of BC, where she scaled programs dramatically during a period of rapid organizational growth. She has also spent over a decade delivering hands-on environmental education through the Habitat Conservation Trust Foundation and its WildBC program, empowering communities to better understand and protect the natural world.Jennie holds a Master's in Environmental Education and a Bachelor's in Conservation Biology from University of British Columbia, and she brings both scientific grounding and deep community experience to her mission: making nature a daily, accessible part of people's lives - and a cornerstone of healthier societies.#NatureAsMedicine #HealthyByNature #ParkPrescriptions #PaRx #PreventiveHealth #PublicHealthInnovation #MentalHealth #Longevity #BehaviorChange #EnvironmentalHealth #Biodiversity #ClimateAndHealth #OutdoorWellness #NatureTherapy #HealthcareInnovation #FutureOfHealth #PopulationHealth #WellnessStrategy #UrbanNature #HealthOptimization #BiohackingNature #Sustainability #BCParks #HumanPerformance #NatureConnectionSupport the show

Polypharmacy is one of the most common—and often overlooked—challenges in modern healthcare, especially in older adults. It's not just about the number of medications a patient is taking, but whether each one still has a clear indication, is providing benefit, and isn't causing harm. As medication lists grow, so does the risk of adverse effects, drug interactions, and something we see all the time in practice: the prescribing cascade. A prescribing cascade happens when a medication causes a side effect that is misinterpreted as a new medical condition, leading to the addition of another drug. Over time, this can snowball into unnecessary complexity and increased risk for patients. In part 2 of this podcast, we outline 5 more examples that I’ve encountered in my geriatric pharmacist practice. Be sure to check out our free Top 200 study guide – a 31 page PDF that is yours for FREE! Support The Podcast and Check Out These Amazing Resources! NAPLEX Study Materials BCPS Study Materials BCACP Study Materials BCGP Study Materials BCMTMS Study Materials Meded101 Guide to Nursing Pharmacology (Amazon Highly Rated) Guide to Drug Food Interactions (Amazon Best Seller) Pharmacy Technician Study Guide by Meded101

Blair Thielemier, a pharmacist, and PQS Customer Success EQUIPP Copilot Specialist, shares her experience leading a group of 12 healthcare professionals on a nine-day Healing Medicine Retreat through Ecuador and the Galapagos Islands, a trip designed to help providers unplug, recharge, and reconnect with themselves.This episode, hosted by PQS Associate Director of Pharmacy Accounts Nick Dorich, covers why providers struggle to truly unplug, how the retreat is intentionally structured to address that (private villa, customized meals, wildlife excursions, yoga, and meditation), and how the experience can carry over into healthier daily habits back home. Blair also touches on the group dynamic — like-minded professionals vetted through 1:1 calls — and announces upcoming retreats in November 2026 and April 2027. https://www.linkedin.com/in/btpharmacyconsulting/

Menopause care has a memory problem. Many of us were trained in the shadow of the Women's Health Initiative, where “hormones” became shorthand for danger, and a whole generation of clinicians stepped back from menopausal hormone therapy. But the products, delivery methods, and the evidence base have moved on, and women are the ones paying the price when we don't keep up. We're joined by naturopath, educator, and integrative co-prescribing specialist Tracee Blythe to talk through what modern MHT can look like in Australia, especially for perimenopause and menopause symptoms that wreck sleep, mood, joints, relationships and daily function. We unpack body-identical oestradiol and micronised progesterone, why unopposed oestrogen is a different risk conversation, and how route of delivery changes the clinical picture. Transdermal patches and gels can avoid first-pass liver effects and support steadier levels, while vaginal oestrogen can offer targeted relief for genitourinary syndrome of menopause with minimal systemic impact for most women. We also go into the real-world questions practitioners hear every day: what about soy and phytoestrogens, what's food versus supplements, and how do we give evidence-based guidance without fear-mongering? Underneath it all is a bigger theme we keep coming back to: lifespan, health span and joy span. If a tool helps a woman sleep, think clearly, move without pain and feel like herself again, we should be able to discuss it openly and safely as part of holistic care. If you want deeper training, Tracy's webinar on confident, integrative co-prescribing for MHT covers pharmacokinetics, interactions, red flags, monitoring, and when to refer and co-manage. Find Tracy on Instagram at @safe_co-prescribing, and if this conversation helps, subscribe, share it with a colleague, and leave us a review so more women can access better menopause support.Shownotes and references are available on the Designs for Health websiteRegister as a Designs for Health Practitioner and discover quality practitioner- only supplements at www.designsforhealth.com.auFollow us on SocialsInstagram: DesignsforhealthausFacebook: DesignsforhealthausDISCLAIMER: The Information provided in the Wellness by Designs podcast is for educational purposes only; the information presented is not intended to be used as medical advice; please seek the advice of a qualified healthcare professional if what you have heard here today raises questions or concerns relating to your health

In this episode, we explore how pregnancy reshapes the pharmacokinetics of psychiatric medications — and what that means for your patients. Can stopping a mood stabilizer actually put a pregnancy at greater risk than continuing it? Dr. Amanda Koire breaks down the evidence. Faculty: Amanda Koire, M.D. Host: Richard Seeber, M.D. Learn more about our memberships here Earn 0.5 CME: Prescribing in Pregnancy: What Every Clinician Should Know Pregnancy's Impact on Medication Efficacy and Dosing Considerations

Polypharmacy isn't just about medication count—it's about cumulative risk and unintended consequences. One of the biggest drivers is the prescribing cascade, where a drug side effect is mistaken for a new condition, and another medication gets added instead of addressing the root cause. You see this all the time in practice. A patient starts amlodipine and develops edema, then gets placed on furosemide. Or donepezil leads to urinary symptoms, and oxybutynin is added—potentially worsening cognition. These patterns add risk quickly. In this episode, I’ll break down common examples that I have recently encountered in practice. Be sure to check out our free Top 200 study guide – a 31 page PDF that is yours for FREE! Support The Podcast and Check Out These Amazing Resources! NAPLEX Study Materials BCPS Study Materials BCACP Study Materials BCGP Study Materials BCMTMS Study Materials Meded101 Guide to Nursing Pharmacology (Amazon Highly Rated) Guide to Drug Food Interactions (Amazon Best Seller) Pharmacy Technician Study Guide by Meded101

Pharma brands invest millions to bring specialty medications to market — and then watch patients abandon therapy before it begins. The culprit is friction within the prescribing workflow: prior authorization requirements that providers don't anticipate, scripts sent to a pharmacy that can't fill them and administrative complexity that makes physicians hesitant to prescribe in the first place. DrFirst chief medical officer Dr. Colin Banas and EVP, corporate strategy Drew Hunsinger join The MM+M Podcast to discuss what happens between the moment a physician decides to prescribe a specialty medication and the moment a patient starts therapy, and what that means for your brand performance. They'll explore how embedding intelligent decision support directly into the prescribing workflow helps providers write clean prescriptions that arrive at the pharmacy ready to fill, and why solving this upstream problem is the next frontier for pharma access strategy. Check us out at: mmm-online.com Follow us: YouTube: @MMM-onlineTikTok: @MMMnewsInstagram: @MMMnewsonlineTwitter/X: @MMMnewsLinkedIn: MM+M To read more of the most timely, balanced and original reporting in medical marketing, subscribe here.Music: “Deep Reflection” by DP and Triple Scoop Music. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Prescribing medication has become unfathomably complex these days, with rules interposed between the patient and physician by pharmacies, payers, and pharmacy benefit managers (PBMs). Drew Hunsinger, Executive VP, Corporate Strategy at DrFirst, points out that a single medication may have multiple indications (conditions for which it can be prescribed) and rules vary by indication. Colin Banas, MD, Chief Medical Officer, says that 90% of new medications are considered specialty medications with associated complex rules.Learn more about DrFirst: https://drfirst.com/Healthcare IT Community: https://www.healthcareittoday.com/

Dr. Jack Cush reviews the news and journal articles from this past week on RheumNow.com.

Editor's Summary by Linda Brubaker, MD, and Preeti Malani, MD, MSJ, Deputy Editors of JAMA, the Journal of the American Medical Association, for articles published from April 11-17, 2026.

Prescribing a Contraindicated Drug I’m David Holub, an attorney focusing on personal injury law in northwest Indiana. Welcome to Personal Injury Primer, where we break down the law into simple terms, provide legal tips, and discuss personal injury law topics. Today’s question comes from a caller who said his doctor prescribed the antibiotic Ciproflaxin (Cipro) […] The post Ep 360 Prescribing a Contraindicated Drug first appeared on Personal Injury Primer.

What are the MAIN benefits of Estrogen for Women? Let's take a deep dive into it!There are some do's and don'ts when it comes to estrogen benefits and prescription medications. 1.  Estradiol (17B Estradiol) only. Why? Estriol isnot very breast friendly 2.  Do not use Estriol or synthetics. Why? 3.  BCP's do NOT equal HRT 4.  Oral Estradiol 1 mg or should be highly referredone. Topical – why? Top 3 killers in women – decreases MI, decreases strokes,decreased Type 2 Diabetes 5.  There is no solid cause and effect or evidenceEstradiol causes breast cancer, HER2 ER increase. Having receptors does notincrease cause and effect – it is not the causation  6.  Do not take orally if you have hypertension 7.  Do not take orally if strong family history ofblood clots or pulmonary embolism 8.  Do not take orally if you have Factor 5 Leiden 9.  Do not take orally if you are outside the “Ten-YearWindow” – what is the “Ten-Year Window”? 10.  Do not take if within 5 years of breastcancer, or if your oncologist says not too. Why?a.       I don't want my license being questionedb.       I don't want to get sued if some rare chance youget breast cancer.If you have any questions, visit my site at danpursermd.com or email at info@danpursermd.com

Denise and Alastair respond to a listener's questions about the management of chronic homeopathic cases, with particular attention to prescribing method, follow-up, and patient autonomy.Topics include:How do you know when a remedy has completed its action?Is it less possible to treat chronic conditions using 4th edition prescribing instead of the 6th?Should a homeopath tell a client what remedy they are taking?This listener also asked about whether or not chiropractic care, massage therapy, and psychotherapy are contraindicated when working with a homeopath…we'll cover adjunct therapies in a future episode so stay tuned!Strange, Rare & Peculiar is a weekly podcast with Denise Straiges and Alastair Gray of the Institute for the Advancement of Homeopathy and the Academy of Homeopathy Education.This season, we're focusing on truth — what it means to Aude Sapere (“dare to know”) in homeopathy today. From Hahnemann's original insights to the realities of modern practice, research, and education, Denise and Alastair bring over 50 years of experience to conversations that challenge assumptions and invite curiosity.

Internal medicine and functional medicine physician Shiv K. Goel discusses the article "Why lifestyle matters more than BPC-157 and semaglutide." Shiv explains how the modern longevity boom has trained patients to seek out quick fixes like peptides and weight loss injections while ignoring foundational habits. He shares a compelling patient story to illustrate why optimizing sleep, circadian rhythms, and stress management is far more powerful than any supplement drawer. Shiv argues that tracking endless biomarkers with wearables without understanding a patient's personal story only creates anxiety. By prioritizing deep listening and addressing the root causes of metabolic dysfunction, clinicians can offer real solutions rather than just another health care transaction. Discover how aligning your daily routines with your biology is the ultimate biohack for a longer, healthier life. Partner with me on the KevinMD platform. With over three million monthly readers and half a million social media followers, I give you direct access to the doctors and patients who matter most. Whether you need a sponsored article, email campaign, video interview, or a spot right here on the podcast, I offer the trusted space your brand deserves to be heard. Let's work together to tell your story. PARTNER WITH KEVINMD → https://kevinmd.com/influencer SUBSCRIBE TO THE PODCAST → https://www.kevinmd.com/podcast RECOMMENDED BY KEVINMD → https://www.kevinmd.com/recommended

Send us Fan MailDoctors are prescribing eating disorders to fat patients — not by accident, not in spite of the guidelines, but because of them. In this episode, I bring the clinical evidence to back up what the fat community has known for years: that severe dieting causes eating disorders, that eating disorders look nothing like the stereotype, and that fat people with eating disorders are being failed at every stage — dismissed, gaslit, and denied treatment. If you've been told to lose weight by a healthcare professional, you have the right to ask them why they're willing to put you at risk. This is the data. These are the receipts. A selection of studies to start you off:Peebles, Rebecka et al. “Are diagnostic criteria for eating disorders markers of medical severity?.” Pediatrics vol. 125,5 (2010): e1193-201. doi:10.1542/peds.2008-1777Sawyer, Susan M et al. “Physical and Psychological Morbidity in Adolescents With Atypical Anorexia Nervosa.” Pediatrics vol. 137,4 (2016): e20154080. doi:10.1542/peds.2015-4080Moskowitz, L., & Weiselberg, E. (2017). "Anorexia nervosa/atypical anorexia nervosa." Current Problems in Pediatric and Adolescent Health Care, 47(4), 70-84.Got a question for the next podcast? Let me know!Connect With MeWEEKLY NEWSLETTER: Get a free script when you sign upTHE WEIGHTING ROOM: Community with a neurodivergent flavour. **BOOK CLUB** exclusive to Weighting Room members. CONSULTATION: For the ultimate transformation in your healthcare journeyMASTERCLASS LIBRARY: Become an expert in your condition and the weight inclusive ways to manage itFREE GUIDES:Evidence-based, not diet nonsenseFind me on Instagram, YouTube, and LinkedIn.

In this episode, Dr Bryony Alderman, palliative care consultant and RCP sustainability clinical education fellow, joins Dr Vasiliki Thanopoulou, rheumatology registrar and RCP clinical education fellow, for a wide‑ranging discussion demystifying modern palliative care.Together they explore how the specialty has evolved beyond end‑of‑life support, highlighting early integration, symptom management across disease groups, and the importance of compassionate, individualised care.The conversation dives deep into practical clinical considerations: appropriate timing of referrals, anticipatory prescribing, managing medications in renal/hepatic failure, handling chronic disease therapies at the end of life, and common misconceptions around syringe drivers. They also discuss communication challenges, including uncertainty in prognostication, hydration and nutrition decisions, and supporting families during difficult conversations.This is an essential episode for clinicians looking to enhance confidence and skill in end‑of‑life care, while keeping person‑centred care at the heart of practice.Resources https://www.spict.org.uk/Lee C, Tran TT, Ross J Anticipatory prescribing in community end-of-life care BMJ Supportive & Palliative Care 2024;14:353-357https://www.parkinsons.org.uk/professionals/resources/nil-mouth-medication-dose-calculators-and-guidelineshttps://www.diabetes.org.uk/for-professionals/improving-care/clinical-recommendations-for-professionals/diagnosis-ongoing-management-monitoring/end-of-life-carehttps://www.nacel.nhs.uk/about-nacelExplore our CPD portfolio by your career stageRCP | Education and professional developmentRCP LinksEducationRCP Social MediaInstagramLinkedInFacebookBlueskyMusic Episode 50 onward - Bensound.com  Episodes 1 - 49 'Impressive Deals' - Nicolai Heidlas Any adverts within this podcast may use computer generated voices

Contact us and share your opinionRules and application here, submissions by 18th March: https://tpp-uk.com/systmone-gp-excellence-awards-categories/Join DrGandalf and Team GP in primary care as they show off how to use TPP SystmOne to support caring and long-term condition (LTC) efficiency in practice and excellence in prescribing safely, with the chance to win £1000 for each award.Boost your triage skills with our dynamic 5-session live webinar course, tailored for primary care clinicians. Led by Dr. Gandalf and Dr. Ed Pooley, this comprehensive training covers all facets of remote patient triage—digital, on-call, and more. Gain practical knowledge, exclusive tips, and direct access to our experts through open Q&A sessions. Elevate your ability to manage primary care challenges effec Subscribe and hear the latest EPIC episode. Join Dr Mike as he shares how to get started and fly using EMIS to make your life easier with this clinical systembit.ly/EMIScourse

Have you ever considered how the symptoms we experience in the early stages of our lives influence who we become later in life? In today's episode, Koby will discuss the first six life chapters and how it's important for homeopaths to cover these in their case taking to see if there are any traumas or unresolved issues in any of these life chapters that may need to be addressed, as well as how this knowledge will guide us through determining the kind of life it will reflect in the future. Koby Nehushtan is a certified therapist in classical homeopathy (a graduate of George Vithoulkas' International Academy of Classical Homeopathy) and Chinese medicine. During his career, he also studied additional methods of treatment, including Tibetan medicine and Ayurveda-Indian medicine. As a practitioner, he also worked and studied in various countries as a member of medical delegations to Africa, as well as in England and New York. Today, as part of an innovative project to establish a medical center in Spain specializing in natural healing methods, Koby is training its team of classical homeopathic therapists. Check out these episode highlights: 04:53 - The first life chapter - Parental Transference  06:49 - How our sufferings are influenced by past generations 10:08 - The second life chapter - Conception 14:53 - The third life chapter - The pregnancy of the mother 19:02 - The fourth life chapter - The delivery 24:46 - What kind of potency is used for birth trauma 29:16 - The fifth life chapter - The first year of birth 31:10 - The sixth life chapter - Between one year old to five years old 34:34 - The symptoms we've observed in children become predictors of who they'll become in the future 37:17 - What is the symptomatology of your evolution Find out more about Koby Website: http://kobynehushtan.co.il/ Facebook: https://www.facebook.com/koby.nehushtan/ LinkedIn: https://www.linkedin.com/in/koby-nehushtan-4270741b9/ Email: kobynn@yahoo.com If you would like to support the Homeopathy Hangout Podcast, please consider making a donation by visiting www.EugenieKruger.com and click the DONATE button at the top of the site. Every donation about $10 will receive a shout-out on a future episode.   Join my Homeopathy Hangout Podcast Facebook community here: https://www.facebook.com/groups/HelloHomies Follow me on Instagram https://www.instagram.com/eugeniekrugerhomeopathy/   Here is the link to my free 30-minute Homeopathy@Home online course: https://www.youtube.com/watch?v=vqBUpxO4pZQ&t=438s   Upon completion of the course - and if you live in Australia - you can join my Facebook group for free acute advice (you'll need to answer a couple of questions about the course upon request to join): www.facebook.com/groups/eughom

After Tony's wife died, days would go by without him speaking to anyone. Then he got a live-in AI robot called ElliQ. It chats to him, plays games with him and reminds him to eat and exercise. Since ElliQ arrived, Tony has been much less lonely. In this episode: policymakers are trialling AI companions to help tackle loneliness among elderly and vulnerable populations. But can machines really replace human company? And are we outsourcing care for marginalised communities to robots?Featuring Anthony Niemiec, Anh Hee Soon, Ki Kyung-eun, Greg Olsen, director of New York State Office for the Aging, and Caroline Green, director of research at the University of Oxford's Institute for Ethics in AI.Check out some of the FT's reporting on this subject on FT.com:The reality of chatbot-induced delusionsCan ChatGPT help with a midlife crisis? The problem with AI and ‘empathy'Artificial Intimacy is presented by Cristina Criddle and produced by Persis Love and Edwin Lane. Additional reporting and production by Jen Kwon and Michela Tindera. The executive producer is Flo Phillips. Sound design is by Breen Turner and Sam Giovinco. The FT's global head of audio is Cheryl Brumley.The FT does not use generative AI to voice its podcasts.Read a transcript of this episode on FT.com Hosted on Acast. See acast.com/privacy for more information.

Credits: 0.25 AMA PRA Category 1 Credit™   CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-475 Overview: A prescribing cascade occurs when adverse effects of a medication are mistaken for a new condition and treated with additional drugs. Older adults experiencing polypharmacy are most at risk. The impact of prescribing cascades can be substantial, leading to falls, organ injury, unnecessary imaging and tests, and more. Join us as we explore how to recognize and prevent these harmful cascades in your patients. Episode resource links: Adrien  O, Mohammad  AK, Hugtenburg  JG,  et al.  Prescribing cascades with recommendations to prevent or reverse them: a systematic review.   Drugs Aging. 2023;40(12):1085-1100. doi:10.1007/s40266-023-01072-yPubMedGoogle ScholarCrossref   Brath  H, Mehta  N, Savage  RD,  et al.  What is known about preventing, detecting, and reversing prescribing cascades: a scoping review.   J Am Geriatr Soc. 2018;66(11):2079-2085. doi:10.1111/jgs.15543PubMedGoogle ScholarCrossref   Daunt R, McGettigan S, Kelly L, Curtin D, O'Mahony D. Detection of Potential Prescribing Cascades in Multimorbid Older Patients Hospitalised with Acute Illness-An Observational Prospective Prevalence Study. Drugs Aging. 2025;42(6):535-546. doi:10.1007/s40266-025-01201-9   Growdon ME, Tjota N, Campbell R, et al. Decision-Making and Downstream Outcomes of the Gabapentinoid-Diuretic Prescribing Cascade. JAMA Netw Open. 2025;8(12):e2545274. doi:10.1001/jamanetworkopen.2025.45274   McCarthy  LM, Savage  R, Dalton  K,  et al.  ThinkCascades: a tool for identifying clinically important prescribing cascades affecting older people.   Drugs Aging. 2022;39(10):829-840. doi:10.1007/s40266-022-00964-9PubMedGoogle ScholarCrossref   O'Mahony, D., Cherubini, A., Guiteras, A.R. et al. STOPP/START criteria for potentially inappropriate prescribing in older people: version 3. Eur Geriatr Med 14, 625–632 (2023). https://doi.org/10.1007/s41999-023-00777-y   Rochon, P.A., O'Mahony, D., Cherubini, A. et al. International expert panel's potentially inappropriate prescribing cascades (PIPC) list. Eur Geriatr Med 16, 1573–1584 (2025). https://doi.org/10.1007/s41999-025-01215-x   Young EH, Pan S, Yap AG, Reveles KR, Bhakta K. Polypharmacy prevalence in older adults seen in United States physician offices from 2009 to 2016. PLoS One. 2021;16(8):e0255642. Published 2021 Aug 3. doi:10.1371/journal.pone.0255642 Guest: Susan Feeney, DNP, FNP-BC, NP-C   Music Credit: Matthew Bugos Thoughts? Suggestions? Email us at FranklySpeaking@pri-med.com  The views expressed in this podcast are those of Dr. Domino and his guests and do not necessarily reflect the views of Pri-Med.

Credits: 0.25 AMA PRA Category 1 Credit™   CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-475 Overview: A prescribing cascade occurs when adverse effects of a medication are mistaken for a new condition and treated with additional drugs. Older adults experiencing polypharmacy are most at risk. The impact of prescribing cascades can be substantial, leading to falls, organ injury, unnecessary imaging and tests, and more. Join us as we explore how to recognize and prevent these harmful cascades in your patients. Episode resource links: Adrien  O, Mohammad  AK, Hugtenburg  JG,  et al.  Prescribing cascades with recommendations to prevent or reverse them: a systematic review.   Drugs Aging. 2023;40(12):1085-1100. doi:10.1007/s40266-023-01072-yPubMedGoogle ScholarCrossref   Brath  H, Mehta  N, Savage  RD,  et al.  What is known about preventing, detecting, and reversing prescribing cascades: a scoping review.   J Am Geriatr Soc. 2018;66(11):2079-2085. doi:10.1111/jgs.15543PubMedGoogle ScholarCrossref   Daunt R, McGettigan S, Kelly L, Curtin D, O'Mahony D. Detection of Potential Prescribing Cascades in Multimorbid Older Patients Hospitalised with Acute Illness-An Observational Prospective Prevalence Study. Drugs Aging. 2025;42(6):535-546. doi:10.1007/s40266-025-01201-9   Growdon ME, Tjota N, Campbell R, et al. Decision-Making and Downstream Outcomes of the Gabapentinoid-Diuretic Prescribing Cascade. JAMA Netw Open. 2025;8(12):e2545274. doi:10.1001/jamanetworkopen.2025.45274   McCarthy  LM, Savage  R, Dalton  K,  et al.  ThinkCascades: a tool for identifying clinically important prescribing cascades affecting older people.   Drugs Aging. 2022;39(10):829-840. doi:10.1007/s40266-022-00964-9PubMedGoogle ScholarCrossref   O'Mahony, D., Cherubini, A., Guiteras, A.R. et al. STOPP/START criteria for potentially inappropriate prescribing in older people: version 3. Eur Geriatr Med 14, 625–632 (2023). https://doi.org/10.1007/s41999-023-00777-y   Rochon, P.A., O'Mahony, D., Cherubini, A. et al. International expert panel's potentially inappropriate prescribing cascades (PIPC) list. Eur Geriatr Med 16, 1573–1584 (2025). https://doi.org/10.1007/s41999-025-01215-x   Young EH, Pan S, Yap AG, Reveles KR, Bhakta K. Polypharmacy prevalence in older adults seen in United States physician offices from 2009 to 2016. PLoS One. 2021;16(8):e0255642. Published 2021 Aug 3. doi:10.1371/journal.pone.0255642 Guest: Susan Feeney, DNP, FNP-BC, NP-C   Music Credit: Matthew Bugos Thoughts? Suggestions? Email us at FranklySpeaking@pri-med.com  The views expressed in this podcast are those of Dr. Domino and his guests and do not necessarily reflect the views of Pri-Med.

Today we are joined by Mr. Brady Kaupa, a Mayo Clinic Department Optician. Tune in as we bring optical clarity on topics from tint to transitions and protection to 3D printing.  Subscribe to the podcast:  https://MayoClinicOphthalmology.podbean.com   Follow and reach out to us on X and IG: @mayocliniceye

Supplement prescribing in primary mitochondrial disease is almost universal, yet highly individualised, stepwise, and non-uniform across regions and phenotypes, with real potential for tissue and pill-burden harm. This podcast features Dr Julia Neugebauer and Professor Shamima Rahman exploring findings of a recent MetabERN survey looking at what informs when clinicians start, monitor, and sometimes stop enzymes and co-factors, and how global registry and natural-history data may guide the field forward. Current global vitamin and cofactor prescribing practices for primary mitochondrial diseases: Results of a European reference network survey Julia Neugebauer, et al https://doi.org/10.1002/jimd.12805 And the editorial discussed: Should the "mitochondrial cocktail" be a default option? An opinion Peter W Stacpoole, Stephen D Cederbaum https://doi.org/10.1016/j.ymgme.2025.109264

Listen in as our expert panel reviews important concepts behind antimicrobial stewardship along with tips to help limit unnecessary antimicrobial use.Special guests:Madeline King, PharmD, MPH, BCIDPCo-Director, Outpatient Antimicrobial StewardshipCooper University Health CareAssistant Professor of MedicineCooper Medical School at Rowan UniversityMichael A. Deaney, PharmD, AAHIVPInfectious Diseases Clinical Pharmacy SpecialistDenver Health & Hospital AuthorityYou'll also hear practical advice from panelists on TRC's Editorial Advisory Board:Stephen Carek, MD, CAQSM, DipABLMClinical Associate Professor of Family MedicinePrisma Health/USC-SOMG Family Medicine Residency ProgramUSC School of Medicine GreenvilleCraig D. Williams, PharmD, FNLA, BCPSClinical Professor of Pharmacy PracticeOregon Health and Science University For the purposes of disclosure, Dr. Madeline King reports a relevant financial relationship with Shionogi (speakers bureau for cefiderocol).The other speakers have nothing to disclose.  All relevant financial relationships have been mitigated.This podcast is an excerpt from one of TRC's monthly live CE webinars, the full webinar originally aired in January 2026.Use code mt1026 at checkout for 10% off a new or upgraded subscription.TRC Healthcare offers CE credit for this podcast. Log in to your Pharmacist's Letter, Pharmacy Technician's Letter,or Prescriber Insights account and look for the title of this podcast in the list of available CE courses.Claim CreditThe clinical resources related to this podcast are part of a subscription to Pharmacist's Letter, Pharmacy Technician's Letter, and Prescriber Insights: Toolbox: Antimicrobial StewardshipAlgorithm: Investigating Possible Drug AllergyCE Course: Implementing Rapid Diagnostic TestingChart: Antibiotic Therapy: When Are Shorter Courses Better?Send a text*****

Prescribing in pregnancy can feel intimidating, especially when a patient casually mentions they're 10 weeks along mid-visit. In this minisode, Kaitlyn and Courtney break down the core principles you need to confidently treat common pregnancy complaints, including first-line options for nausea, reflux, and infections, and which antibiotics are safe and when to avoid certain ones on boards and in practice.         Follow us on Instagram: instagram.com/smnpreviewsofficial

On this episode of danatech Talks, a special series from The Huddle: Conversations with the Diabetes Care Team, Dana Moreau is joined by Amy Hess-Fischl, MS, RD, LDN, CDCES, to explore the real-world challenges of prescribing diabetes technology. Amy shares practical strategies for navigating coverage pathways, documentation requirements, denials, and affordability, while offering workflow tips to help providers streamline access for their patients. This episode was supported by educational grant funding from Abbott. Explore the latest in diabetes technology as well as trainings and resources on danatech: danatech l Diabetes Technology Education for Healthcare Professionals Listen to the first episode of our danatech Talks diabetes technology series: https://thehuddle.simplecast.com/episodes/basics-diabetes-technology-for-health-care-professionals Listen to more episodes of The Huddle at https://www.adces.org/practice/the-huddle-podcast Learn more about ADCES and the many benefits of membership at adces.org/join. The Huddle Podcast is edited by JAG Podcast Productions: https://jagpodcastproductions.com/ Hosted by Simplecast, an AdsWizz company. See https://pcm.adswizz.com for information about our collection and use of personal data for advertising.

Four years after our original antibiotic myth-busting episode (Ep 60), we're back with Dr Riati Scarborough to talk antibiotic prescribing habits. This time we're joined by fellow stewardship expert Dr Laura Hardefeldt, and this time we're asking the harder question: Have we actually changed?The good news? Some prescribing habits are shifting. We're seeing shorter courses and less ‘just in case antibiotic usage. But let's not pat ourselves on the back too quickly. Because some of our most entrenched habits are still alive and well, like how we treat skin disease, and our ongoing love affair with amoxiclav.This episode is a practical, clinically grounded update on what the evidence says in 2026 - and how to make realistic changes without compromising patient care.We cover:Why skin disease remains the single biggest driver of antimicrobial resistance in small animal practice, and what to do about itAmoxicillin vs amoxiclav: when de-escalation is not just safe, but smarterWhy convenience (you know the brand we're talking about right…) is not a clinical indicationTrimethoprim-sulphonamide and the real story on KCS riskDentals, heart murmurs, and what prophylaxis actually looks like in 2026Simple in-clinic stewardship strategies that genuinely shift prescribing behaviourThis isn't about perfection. It's about progress.If you'd like effective antibiotics to still exist in five to ten years…This episode is essential listening.Find out how we can support you in your vet career at ⁠⁠⁠⁠⁠⁠⁠thevetvault.com⁠⁠⁠⁠⁠⁠⁠.⁠Subscribe to our weekly newsletter⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠here⁠⁠⁠⁠⁠⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠for Hubert's favourite clinical and non-clinical learnings from the week.Grab one last handful of spots in the Maldives for our surf/dive vet conference with ⁠Vets On Tour⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠. Tips and Timestamps3:03 Progress in prescribing habits including UTI durations and surgical prophylaxis4:55 Skin disease as the biggest problem area in small animal practice7:01 Topical therapy versus systemic antibiotics for skin conditions9:28 Deep pyoderma and the new consensus statement11:00 Gut bacteria as a source of resistant infections12:41 Rise of MRSP, methicillin-resistant Staphylococcus pseudintermedius14:00 Amoxicillin-clavulanate overuse16:47 Vets on Tour conferences advertisement18:08 Pharmacology refresher on amoxicillin, amoxicillin-clavulanate, and cefovecin19:45 Why cefovecin is classified as high importance, vs the convenience argument for cefovecin in cats22:56 Long-acting amoxicillin injections as an alternative24:00 Getting amoxicillin back on the shelf24:53 Communicating antibiotic choices to clients29:32 Dental antibiotics and debunking the heart murmur myth34:07 Subclinical bacteriuria and stopping cultures in asymptomatic patients38:30 Reassessing the dry eye risk of trimethoprim-sulfonamide41:43 Antimicrobial stewardship trial using colour-coded pharmacy shelves

HOUR 2: If we know that certain medications can make you homicidal...why are we still prescribing them? full 2278 Mon, 09 Feb 2026 21:00:00 +0000 2AxO8VdvN1BDuWV8vrbGNygoH1tHo8ij news The Dana & Parks Podcast news HOUR 2: If we know that certain medications can make you homicidal...why are we still prescribing them? You wanted it... Now here it is! Listen to each hour of the Dana & Parks Show whenever and wherever you want! © 2025 Audacy, Inc. News False

In this episode, we explore a critical drug interaction: SSRIs combined with anticoagulants increase major bleeding risk by 35-47%. Should age and sex change our prescribing decisions? We break down the evidence from nearly 100,000 patients and discuss safer antidepressant alternatives for high-risk individuals. Faculty: Paul Zarkowski, M.D. Host: Richard Seeber, M.D. Learn more about our membership here Earn 0.75 CME: Quick Take Vol. 77 Do SSRIs Increase Major Bleeding Risk with Oral Anticoagulants?

Research Looks into the Unnecessary Prescribing of Antibiotics Among DentistsBy Today's RDH ResearchOriginal article published on Today's RDH: https://www.todaysrdh.com/research-looks-into-the-unnecessary-prescribing-of-antibiotics-among-dentists/Need CE? Start earning CE credits today at ⁠⁠https://rdh.tv/ce⁠⁠ Get daily dental hygiene articles at ⁠⁠https://www.todaysrdh.com⁠⁠ Follow Today's RDH on Facebook: ⁠⁠https://www.facebook.com/TodaysRDH/⁠⁠Follow Kara RDH on Facebook: ⁠⁠https://www.facebook.com/DentalHygieneKaraRDH/⁠⁠Follow Kara RDH on Instagram: ⁠⁠https://www.instagram.com/kara_rdh/⁠

GLP-1 medications have become an important part of adult obesity treatment and are now increasingly relevant in pediatric care. As new approvals emerge and clinical guidance continues to evolve, pediatricians are being asked to consider when, and for whom, these therapies may be appropriate. In this episode, we review the current evidence, discuss clinical considerations and examine the evolving role of GLP-1 medications in child and adolescents. Megan Kelsey, MD, is the medical director of both lifestyle medicine and adolescent bariatric surgery. Jaime Moore, MD, specializes in pediatric nutrition and obesity medicine. Both Drs. Moore and Kelsey are on the faculty here at the University of Colorado School of Medicine. Some highlights from this episode include: How GLP-1s are changing lives for kids with obesity  Learning how they work and are administered  The average effect of these medications  The future of use as access to these medications becomes easier Below are some resources mentioned in this episode: Institute for Healthy Childhood Weight University of Minnesota: Virtual Advanced Therapies for Pediatric Obesity Conference For more information on Children's Colorado, visit: childrenscolorado.org. 

After getting completely hacked and losing our entire social media presence, we're pivoting HARD - and it might be exactly what we needed.In this raw, unfiltered episode, Dr. Matthew Weiner and Zoe break down:- WHY we stopped prescribing the "new" Wegovy pill (spoiler: it's 5 years old and we have data you need to hear)- The GLP-1 medication coming in 2026 that could change everything - Retatrutide clinical trial results revealed- How to get REAL Eli Lilly medication for $150/month (not compounded) through a program most people don't know exists- The AI-powered weight loss app Dr. Weiner is coding himself that does what he does in the office (beta testers wanted!)- Why we're ditching Instagram for Reddit and YouTube - and the surprising reason long-form content beats 30-second clipsPLUS: Real patient stories including a VSG + breast cancer + GLP-1 combination success, the truth about oral vs. injectable semaglutide, home-ground flour health claims investigated, and why that "bulge" when you cough isn't what you think it is.If you're on GLP-1s, considering them, or just tired of BS weight loss advice - this episode cuts through the noise with real data, real experience, and real talk.Like, subscribe, and share with someone who needs to hear this (since we can't share it on Instagram anymore)

It's In the News.. a look at the top headlines and stories in the diabetes community. This week's top stories: UK looks at starting universal T1D screening, Dexcom's CEO mentions a new product, bariatric sugery vs GLP medications, FDA approves update to prescribing info for inhaled insulin, miscroplastic and diabetes link studied, and more! Announcing Community Commericals! Learn how to get your message on the show here. Learn more about studies and research at Thrivable here Please visit our Sponsors & Partners - they help make the show possible! Omnipod - Simplify Life All about Dexcom  T1D Screening info All about VIVI Cap to protect your insulin from extreme temperatures The best way to keep up with Stacey and the show is by signing up for our weekly newsletter: Sign up for our newsletter here Here's where to find us: Facebook (Group) Facebook (Page) Instagram Check out Stacey's books! Learn more about everything at our home page www.diabetes-connections.com  Episode transcription with links: (Stacey Track) Welcome! I'm your host Stacey Simms and this is an In The News episode.. where we bringing you the top diabetes stories and headlines happening now. We are less than one month from our first MNO of 2026. Please join us in Silver Spring MD Feb 20 and 21. It's going to be amazing. We're going to Nashville next March 6-7 and we're going to have a great event a Club 1921 we just added on Thursday March 5th for health care providers and patient leaders. All the info is over at diabetes-connetionss.com events/ Okay.. our top story this week: XX   All UK children could be offered screening for type 1 diabetes using a simple finger-prick blood test, say researchers who have been running a large study. This is the ELSA study - Early Surveillance for Autoimmune diabetes, a first of its kind UK study. They tested blood samples from 17,931 children aged 3-13 for autoantibodies, markers of type 1 diabetes that can appear years before symptoms. Families of children found to have early-stage type 1 diabetes received tailored education and ongoing support to prepare for the eventual onset of type 1 diabetes symptoms and to ensure insulin therapy can begin promptly when needed, reducing the chances of needing emergency treatment. Those with one autoantibody also received ongoing support and monitoring.   Some families were also offered teplizumab, the first ever immunotherapy for type 1 diabetes, which can delay the need for insulin by around three years in people with early-stage type 1 diabetes. The second phase has launched and will expand screening to all children in the UK aged 2-17 years, with a focus on younger children (2-3 years) and older teenagers (14-17 years). The research team aims to recruit 30,000 additional children across these new age groups. ELSA 2 will assess how screening can be scaled across the NHS and evaluate its cost-effectiveness. https://www.birmingham.ac.uk/news/2026/childhood-type-1-diabetes-screening-is-effective-and-could-prevent-thousands-of-emergency-diagnoses XX At the J.P. Morgan Healthcare Conference Dexcom CEO Jake Leach says they're going to launch a new product outside the US. I'll link up that interview, The full quote: "When you look at the outside the U.S., there are a lot of structures that are tiered. Patients have access to different types of products, so we've got a new one that we want to introduce that will add flexibility there. It's based on the G7 platform, just like Dexcom ONE+, but it has a unique experience that's tailored for a subset of users that, today, don't have access to Dexcom." Your guess is as good as mine, but sounds more like a pricing or ordering issue than a new bit of hardware or software. Dexcom will also bring Stelo to some international markets this year. And plans a new mobile app experience for the wearable biosensor meant for people who don't dose insulin. Leach also says G8 will be much smaller and with more capability. but is a few years away. https://www.drugdeliverybusiness.com/dexcom-ceo-jake-leach-2026-roadmap-jpm/ XX A new international consensus statement provides guidance for the use of diabetes technology during pregnancy for women with type 1 diabetes (T1D), type 2 diabetes (T2D), or gestational diabetes (GD).   Organized by the diaTribe Foundation, the document was based on evidence where available, as well as opinion from an international group of experts in endocrinology, diabetes technology, and obstetrics & gynecology, among others.   This is the first set of recommendations specifically addressing the use of diabetes technology in pregnancy – and we'll link it up. https://www.medscape.com/viewarticle/new-consensus-statement-addresses-diabetes-tech-pregnancy-2026a100020d XX Bariatric surgery beats GLP-1s for type 2 diabetes across income levels. This study was published this month, looking at nearly 300 patients are 4 medical centers. Success here is measured by lower blood glucose levels, higher weight loss (28% vs. 10%), less use of diabetes medications, remission of diabetes to the point of no longer needing to inject insulin, and reduced risk factors for cardiovascular disease.     Bariatric surgery was better than medical therapy across all social backgrounds, they found, and not just in areas of higher deprivation. The ancillary study was smaller, and some of the participants randomized in earlier stages crossed over from medical to surgical treatment, and the reverse. The authors acknowledged and accounted for these limitations, along with the rapid development of more powerful obesity drugs not fully captured in the study. This was a long term study – more than 12 years – and by the end of the study more people were choosing GLP1 medications. One dividing line: If someone hopes to lose 100 pounds, that's more likely with surgery than with medications.  "Ultimately, we need large, long-term, well-designed studies to clarify the best strategy for a given patient." https://www.statnews.com/2026/01/19/diabetes-study-bariatric-surgery-better-than-glp-1s/ XX Researchers at the University of California, Riverside have reported for the first time that a father's exposure to microplastics (MPs) can lead to metabolic problems in his children, including diabetes. This is a mouse study, but it looks at a previously unrecognized way in which environmental pollution may influence the health of future generations. MPs are extremely small plastic fragments, measuring less than 5 millimeters, that form as consumer products and industrial materials break down. Metabolic disorders describe a group of conditions that include elevated blood pressure, high blood sugar, and excess body fat, all of which raise the risk of heart disease and diabetes. The team found that female offspring of male mice exposed to MPs were far more prone to metabolic disorders than offspring of unexposed fathers, even though all offspring received the same high fat diet.     The research team hopes the findings will guide future investigation into how MPs and even smaller nanoplastics affect human development.   https://scitechdaily.com/microplastics-can-rewire-sperm-triggering-diabetes-in-the-next-generation/ XX The FDA has finalized four new recalls for certain lots of Abbott's FreeStyle Libre 3 and FreeStyle Libre 3 Plus sensors due to ongoing safety concerns. We told you about this in November when Abbott says some of its continuous glucose monitoring (CGM) sensors were providing incorrect low glucose warnings. Internal testing identified the issue—carbon building up in the sensors during the manufacturing process—and determined that approximately 3 million CGM sensors were affected. The sensors were distributed in the United States, Canada and several European countries.  When Abbott shared that announcement, the FDA was still reviewing the situation. No recalls had yet been finalized. Now, however, the agency has announced four new Class I recalls.   https://cardiovascularbusiness.com/topics/clinical/heart-health/fda-confirms-recalls-abbott-cgm-sensors-new-lawsuit-alleges-company-concealed-information XX   Insulet brings back it's U.S. Pod recycling program, now making it available to all U.S. customers. The Pod recycling program, offered at no cost to customers, enables users to request a recycling kit online. This allows them to return their used Omnipods. Insulet then decontaminates the returned Pods before transporting them to a company specializing in recycling for electronics and medical products. Insulet began recycling pilot programs in Mass and California and are rolling it out nationwide. Insulet also has "Pod takeback" programs outside the U.S. in several international markets. These programs enable customers to request a takeback kit by contacting their local customer support team.   https://www.drugdeliverybusiness.com/insulet-expands-us-pod-recycling-program/ XX Up next a new resource for a population at three times the risk for diabetes, but without a lot of access to health information. I The first diabetes information website primarily in ASL has launched. The site includes GIFs and videos on diabetes management and an ASL glossary of diabetes-related terms. This is from University of Utah Health – Called Deaf Diabetes Can Together. Deaf and hard of hearing people are at three times higher risk for diabetes, but access to health information in ASL is limited. https://healthcare.utah.edu/newsroom/news/2026/01/first-diabetes-information-website-asl-launches XX Novo Nordisk ended all work on cell therapies, including a Type 1 diabetes program, in October – and now has found a buyer. Aspect has acquired rights to the assets and giving Novo an option to reengage for later-stage development and commercialization. Novo is helping bankroll Aspect's development of the assets, investing in the company and providing research funding. The arrangement gives Novo a chance to profit from the programs down the line. Novo is eligible for royalties and milestone payments on future product sales and, having handed the reins to Aspect for now, can expand its role in later-stage development and commercialization. The integration will involve the transfer of capabilities and expertise from Novo sites in Denmark and the U.S. to Aspect's Canadian operations. https://www.fiercebiotech.com/biotech/novo-nordisk-offloads-diabetes-assets-aspect-amid-cell-therapy-retreat XX XX Lucas Escobar has carved a role by proving that healthcare marketing can be culturally resonant, commercially powerful and deeply human. As director and head of U.S. consumer marketing at Insulet, he has redefined how the Omnipod tubeless insulin pump shows up in culture, transforming a medical device into a symbol of identity, inclusion and empowerment.   Under Escobar's leadership, Insulet launched three breakthrough initiatives: Dyasonic: Sound of Strength, a Marvel comic collaboration introducing a superhero who uses Omnipod; The Pod Drop, which turned the sound of a pod change into a celebratory music track; and Omnipod Mango x Pantone, medtech's first color partnership, honoring the vibrancy of the diabetes community. Each blended creativity with purpose while driving results, helping fuel Omnipod's consistent double-digit growth and its position as the most prescribed insulin pump in the U.S.   Living with type 1 diabetes himself, Escobar brings lived experience to his work, using storytelling not just to sell, but to make people feel seen.   Click here to return to the 2026 MM+M 40 Under 40 homepage.   From the January 01, 2026 Issue of MM+M - Medical Marketing and Media https://www.mmm-online.com/40-under-40/40-under-40-lucas-escobar-insulet/ -- FDA approves an update to the prescribing info for Afrezza inhaled insulin. This is a revision to the recommendations for the starting mealtime dosage when patients switch from shots or insulin pumps. This is aimed at healthcare providers - the updated labeling was supported by results from the INHALE-3 trial. The FDA is still considering approval of Afrezza for kids – a decision there expect by summer. https://www.globenewswire.com/news-release/2026/01/26/3225442/29517/en/MannKind-Announces-FDA-Approval-of-Updated-Afrezza-Label-Providing-Starting-Dose-Guidance-when-Switching-from-Multiple-Daily-Injections-MDI-or-Insulin-Pump-Mealtime-Therapy.html   -- UK researchers have developed a calculator to predict whether someone is at risk for type 1 diabetes. They're hoping this helps in screening and in preventing DKA at diagnosis. They used the TEDDY study to create this calculator, which right now is in beta form and only for kids and teens ages 8-18. The current beta form of the calculator asks users to answer questions about four factors necessary to estimate a child's risk of developing type 1 diabetes: age, family history, number of confirmed autoantibodies, and genetic risk score. The calculator has been given regulatory approval as a diagnostic in the U.K., and he's working with a company that's hoping to bring it to the U.S. in the next few months in the form of a home genetic test kit. https://www.healthcentral.com/news/type-1-diabetes/new-calculator-might-help-predict-type-1-diabetes-before-symptoms-appear

One of the most basic pillars of health is good nutrition. A range of eating patterns might all be considered balanced diets, but in general people do better when they eat less processed foods and more whole foods. Vegetables and fruits play a starring role in at least two diets that have been studied extensively, […]

Program notes:0:38 Childhood vaccinations nationally1:30 Across 45 states and DC2:34 Level of vaccine protection3:34 Professional societies stepping in3:51 Skilled nursing facilities 4:51 Estimated operating capacity5:51 Backups into hospitals6:51 Staffing not returned to pre-pandemic levels7:35 Prescribing patterns of CNS active meds in older adults8:36 Several classes of medication examined9:36 Last line medications9:50 Mifepristone regulation historically10:50 Consistent findings on safety11:50 FDA looking at REMS12:50 End

Jacob Ward of The Rip Current joins Mikah Sargent on the show this week! Lego unveils its Smart Brick. Jacob kvetches about AI's overwhelming presence at CES. We get some on-site reporting from CES. And Utah becomes the first state to allow artificial intelligence to renew medical prescriptions. Mikah talks about Lego's new Smart Brick technology that allows you to interact and play with your Lego sets more directly. Jacob shares his thoughts about the overall theme of AI that has become front and center at this year's CES event. Stephen Robles of beard.fm joins the show live from CES to talk about what he saw at the event. And Ruth Reader of POLITICO stops by to talk about Utah being the first state to allow artificial intelligence to begin renewing medical prescriptions for patients. Hosts: Mikah Sargent and Jacob Ward Guests: Stephen Robles and Ruth Reader Download or subscribe to Tech News Weekly at https://twit.tv/shows/tech-news-weekly. Join Club TWiT for Ad-Free Podcasts! Support what you love and get ad-free audio and video feeds, a members-only Discord, and exclusive content. Join today: https://twit.tv/clubtwit Sponsors: joindeleteme.com/twit promo code TWIT zscaler.com/security

Jacob Ward of The Rip Current joins Mikah Sargent on the show this week! Lego unveils its Smart Brick. Jacob kvetches about AI's overwhelming presence at CES. We get some on-site reporting from CES. And Utah becomes the first state to allow artificial intelligence to renew medical prescriptions. Mikah talks about Lego's new Smart Brick technology that allows you to interact and play with your Lego sets more directly. Jacob shares his thoughts about the overall theme of AI that has become front and center at this year's CES event. Stephen Robles of beard.fm joins the show live from CES to talk about what he saw at the event. And Ruth Reader of POLITICO stops by to talk about Utah being the first state to allow artificial intelligence to begin renewing medical prescriptions for patients. Hosts: Mikah Sargent and Jacob Ward Guests: Stephen Robles and Ruth Reader Download or subscribe to Tech News Weekly at https://twit.tv/shows/tech-news-weekly. Join Club TWiT for Ad-Free Podcasts! Support what you love and get ad-free audio and video feeds, a members-only Discord, and exclusive content. Join today: https://twit.tv/clubtwit Sponsors: joindeleteme.com/twit promo code TWIT zscaler.com/security

In Episode 2 of Pharmacist-Prescribed, hosts Mary Kucek, PMP, Founder and CEO of OvaryIt, and Devin Bustin, MD, Chief Medical Officer of OvaryIt, dive into the practical realities of implementing pharmacist-led prescribing services in community pharmacy settings. The conversation explores how pharmacies can navigate state-specific prescribing authority, standing orders, collaborative practice agreements, staffing concerns, and day-to-day workflows without disrupting existing operations. Listeners will gain a clear picture of how the PRISM platform supports safe, compliant, and efficient clinical service delivery, from patient intake and documentation to e-prescribing and team-based care. Learn more about PRISM or request a demo at https://www.getprismrx.com  

This week, in a special holiday edition of The Dr. Hyman Show, I'm revisiting a powerful conversation with Dr. Aseem Malhotra, a leading cardiologist and advocate for ethical, evidence-based medicine, where we unpacked the uncomfortable truths about cholesterol, statins, and what really drives heart disease. Wishing you a peaceful holiday week. We unpack: • Why LDL cholesterol isn't the whole story when it comes to heart disease • How reducing inflammation and insulin resistance can better protect your heart • What statins can—and can't—do to improve real cardiovascular outcomes • How industry influence shapes the prescriptions patients receive Better heart health starts with better information and real progress begins when we stop treating numbers and start treating what's actually causing disease. Hope you have a peaceful holiday week. I look forward to continuing this journey together in the new year. View Show Notes From This Episode Get Free Weekly Health Tips from Dr. Hyman https://drhyman.com/pages/picks?utm_campaign=shownotes&utm_medium=banner&utm_source=podcast Sign Up for Dr. Hyman's Weekly Longevity Journal https://drhyman.com/pages/longevity?utm_campaign=shownotes&utm_medium=banner&utm_source=podcast Join the 10-Day Detox to Reset Your Health https://drhyman.com/pages/10-day-detox Join the Hyman Hive for Expert Support and Real Results https://drhyman.com/pages/hyman-hive This episode is brought to you by Big Bold Health, Sunlighten, Function Health and Pique. Get 20% off HTB Immune Energy Chews at bigboldhealth.com and use code DRMARK20. Head over to sunlighten.com and save up to $1400 or more this holiday season with code HYMAN. Join today at functionhealth.com/mark and use code MARK2026 to get $50 OFF toward your membership. Receive 20% off FOR LIFE + a free Starter Kit with a rechargeable frother and glass beaker at piquelife com/hym